Vanderbilt-Ingram Cancer Center

06/05/2026

Life Fest attendees, keep the momentum going by joining the Walk for Hope! Every step helps support the GIST community through education, advocacy, and research. Register today: https://bit.ly/WalkForHopeLF

06/05/2026

06/05/2026

Nashville Community Pool Swim

06/02/2026

Rethinking recurrence burden in low-grade and intermediate-risk . Sarah Psutka, MD, MS, FACS University of Washington sits down with Ashish Kamat, MD, MBBS Vanderbilt Health to discuss the burden and management of intermediate-risk nonmuscle-invasive . Dr. Psutka highlights that most patients experience three recurrences in five years and require near-indefinite surveillance. > bit.ly/3SganmZ

06/02/2026

Could a policy decision affect whether someone detects cancer early? Absolutely. Cancer screenings aren’t just about doctors and tests. Policy plays a key role in who gets screened and what it costs.

On the latest miniVHAN podcast, Maddie Michael of the American Cancer Society Cancer Action Network discusses how policy shapes cancer prevention and screening across Tennessee. From lowering prostate screening costs to expanding colorectal screening in rural areas, the conversation highlights policy’s impact on early detection and affordability.

Download the entire episode in the link in the first comment.

05/28/2026

Every 2 minutes, someone in the U.S. is diagnosed with lung cancer, but there is hope. Early detection is helping more people survive than ever before.

At Vanderbilt Health, Dr. Fabien Maldonado, Director of Interventional Pulmonology, is leading the way with innovative tools to detect lung cancer earlier and more accurately. Using advanced robotic bronchoscopy paired with Cone-Beam CT, his team creates detailed 3D images of the lungs and performs minimally invasive biopsies.

This approach helps make diagnosis safer, faster, and more precise, giving patients a better chance at successful treatment. Watch interview below.

Fabien Maldonado MD, MSc Director of Interventional Pulmonology at Vanderbilt Health works on novel and innovative ways to diagnose lung cancer.

05/22/2026

RNA sequencing of blood samples may help predict immune response to chemoimmunotherapy and support more personalized treatment strategies for high-risk...

05/22/2026

We’re thrilled to welcome Dr. Kirsten Jorgensen to the Gynecologic Oncology team at Vanderbilt-Ingram Cancer Center! Jorgensen is a fellowship-trained gynecologic oncologist and assistant professor of Obstetrics and Gynecology with Vanderbilt Health.

Jorgensen attended Harvard University for undergraduate studies and then received her medical degree from the University of Washington School of Medicine. She completed residency at Tufts Medical Center, followed by a Gynecologic Oncology fellowship at MD Anderson Cancer Center. She also completed a Master in Public Health in Epidemiology at The University of Texas Health Science Center. Jorgensen specializes in the medical and surgical treatment of cancers of the female reproductive organs, including ovarian, cervical, endometrial, vaginal and vulvar malignancies.

Jorgensen sees patients at the cancer center's Nashville and Lebanon locations. To schedule an appointment, please call 615-936-8422.

05/21/2026

The Vanderbilt-Ingram Cancer Center Young Adult Cancers Program hosted a social gathering last night for young adults with cancer. All young adults with cancer are welcome to attend future events.

To stay informed about upcoming gatherings, subscribe to the YAC newsletter here: https://t.e2ma.net/webview/n95wpi/5c920e980a1fc810102c936acfa380cd

05/20/2026

Cancer research at Vanderbilt-Ingram Cancer Center is changing what’s possible, from earlier detection to more targeted treatments and new paths to recovery. These stories show how research is impacting real lives every day and helping shape better outcomes for patients and families.

Because of cancer research, evolving stem cell transplant therapies are helping patients like Sharon achieve better outcomes and longer survival.

Because of cancer research, clinical trials helped Lily receive a therapy that is now improving outcomes for children with leukemia.

Because of cancer research, Aaron received a noninvasive treatment that destroyed his liver tumor without surgery or the pain of traditional recovery.

Because of cancer research, Laura’s blood test detected cancer at a microscopic level before it could spread, allowing doctors to change her treatment and save her life.

These are just a few stories that reflect what cancer research makes possible. With every breakthrough, we are helping more patients find hope, healing and more time. 🤍

®